Pioneering diagnostics

Clinical Microbiology

The world leader in microbiology (42% market share) bioMérieux possesses unrivalled expertise, a unique international scientific network and an ambitious innovation strategy.

  • Microbiology is based on the culture of biological samples in a medium enabling any bacteria present to multiply. It is an essential technology for the identification of many microorganisms and their susceptibility to the antibiotics tested.
  • It has encountered renewed interest due to:
    • the growing resistance of certain bacteria to antibiotics,
    • the introduction of new technologies and automated solutions:
      • providing more rapid results for faster clinical decisions
      • making the most relevant information easily accessible to clinicians,
      • significantly improving the operational efficiency of laboratories.

Why it’s important

  • Microbiology must respond to major public health challenges such as the development of bacterial resistance and the appearance of new pathogens.
    • Clinicians are becoming increasingly reliant on information from microbiology laboratories as resistance to antibiotics makes therapeutic decisions more complex.
    • The rapid identification of the bacterium responsible for an infection and the antibiotics effective against this bacterium can have an impact on a patient's survival.
    • Tests allow physicians to choose the appropriate treatment and avoid the widespread or inappropriate use of antibiotics, which drive the development of antibiotic resistant bacteria.
  • Laboratory managers are faced with heightened demands due to laboratory consolidation and healthcare budget constraints. They must handle an increasingly complex workflow with a smaller workforce and, in many cases, fewer skilled technicians.

Our product offering

  • bioMérieux is working to address the challenges facing the microbiology lab and providing clinicians with precise, rapid and relevant information for better patient care. New technologies and automated solutions have, during the past decade, significantly reduced the time needed to provide test results.
  • bioMérieux was at the cutting edge of this development, offering innovative solutions to microbiologists.
  • bioMérieux tests are used in active antibiotic monitoring and management programs:
    • screening tests,
    • rapid diagnostic tests,
    • resistance tests (interpretation and orientation of therapy),
    • strain typing,
    • epidemiological monitoring.
  • bioMérieux relies on its long-standing expertise in microbiology, while integrating emerging technologies. We focus on:
    • reducing time-to-results,
    • developing new reagents to expand the range of bacteria that can be detected by our systems and identify resistant bacteria,
    • creating tests to analyze the susceptibility of bacteria to new antibiotics launched by the pharmaceutical industry,
    • developing new culture media,
    • automating the microbiology lab,
    • strengthening connectivity within laboratories.
  • bioMérieux's product offering, which extends from manual to automated methods, is the most comprehensive on the market: